Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Does inhaled corticosteroid use affect the risk of COVID-19-related death?

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Balancing treatment and side-effects in severe asthma: a patient and professional perspective

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Meeting challenges in delivery of patient care: a reflection on the involvement of ERS in CPD of respiratory physicians

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Endobronchial ultrasound: launch of an ERS structured training programme

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Treatment Response Biomarkers in Asthma and COPD

    Research output: Contribution to journalReviewResearchpeer-review

  2. Alfa-1 Antitrypsinmangel

    Research output: Contribution to journalReviewResearchpeer-review

  3. Hydroxychloroquine as a primary prophylactic agent against sars-cov-2 infection: a cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Corticosteroid Resistance in Smokers-A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

ICS does not seem to protect against COVID-19-related mortality, but more data is needed to determine whether it is harmful. Due to its known and important benefits ICS should be prescribed as usual for both asthma and COPD. https://bit.ly/3pWVimX.

Original languageEnglish
Article number200275
JournalBreathe
Volume17
Issue number1
Pages (from-to)200275
Number of pages3
ISSN1810-6838
DOIs
Publication statusPublished - Mar 2021

ID: 66309908